The Effect of the Mind/Body Program for Fertility, Hungarian Version, on Well-Being and Assisted Reproduction Outcomes

May 2, 2023 updated by: Semmelweis University

The Effect of the Mind/Body Program for Fertility, Hungarian Version, on Psychological Well-Being and Assisted Reproduction Technology (ART) Outcomes: A Randomized Controlled Trial

Involuntary childlessness is an emotionally stressful experience; however, psychosocial counseling is typically not available in Hungarian routine fertility care. The aim of this randomized controlled trial (RCT) is to examine the effectiveness of a Mind/Body psychological fertility intervention for women in reproductive treatment. We hypothesize that participants of the Mind/Body Program for Fertility, Hungarian version, will have more favorable psychological well-being, ART outcome results than participants of the Fertility Support Groups.

Study Overview

Detailed Description

Involuntary childlessness imposes significant psychological burden on those affected, particularly those involved in assisted reproductive technology (ART). The reduction of psychological distress has been shown to improve the quality of life of those affected and to possibly increase chances of pregnancy. While in more developed countries psychological support is largely available in routine fertility care, it is not yet part of the Hungarian ART protocol.

In this study, the effects of a psychosocial intervention, namely, the Hungarian version of the Mind/Body Program for Fertility (Domar et al., 2011), will be tested on the psychological well-being and ART outcomes of women in reproductive treatment, in a randomized controlled pre-post design.

For this purpose, women in ART treatment will fill in screening questionnaires (on depression, anxiety, stress, etc.), and moderate to high scorers will be randomized into an intervention (Mind/Body) group (N=70) and a comparison intervention (Fertility Support) group (N=70), lasting for 10 weeks each, before and/or during an ART cycle. Both interventions will be delivered by the same clinical psychologist, listed as central contact person below, officially trained in the Mind/Body Program for Fertility by Dr. Alice Domar at Boston IVF, Waltham, Massachusetts. A smartphone application for rating subjective stress levels twice a day, from the start of the stimulation to the day of the pregnancy test, will also be administered. Additionally, whole-night sleep EEGs will be recorded.

Medical data (such as diagnosis, hormone levels, previous treatment cycles, etc.) and sociodemographic (such as age, education, etc.) and psychological variables (such as personality traits, chronotype, intelligence, etc.) as potential moderators, as well as ART outcomes will be reported. Data of respondents willing to fill in pre- and post-questionnaires but 1) not motivated to take part in the study, or 2) motivated to take part in the study, but not able to make it, will be registered but excluded from statistical analysis comparing RCT results.

Study Type

Interventional

Enrollment (Actual)

177

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Budapest, Hungary, 1082
        • Assisted Reproduction Center of the Department of Obstetrics and Gynecology at Semmelweis University
      • Budapest, Hungary, 1089
        • Institute of Behavioral Sciences at Semmelweis University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 41 years (Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria: All women awaiting or undergoing infertility treatment (insemination, in vitro fertilization or intracytoplasmic sperm injection) at the Assisted Reproduction Center of the Department of Obstetrics and Gynecology at Semmelweis University, Budapest, who:

  • give informed consent to participating in the study
  • have sufficient knowledge of the Hungarian language

Exclusion Criteria:

  • active psychotic episode
  • severe depression or other major psychiatric diagnoses
  • substance abuse
  • eating disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Mind/Body Group
All persons allocated to the intervention group will take part in a 10-week Mind/Body skills development fertility program parallel with fertility workup and treatment.
see Arm Description
Active Comparator: Support Group
All persons allocated to the comparison intervention group will take part in a 10-week fertility support program parallel with fertility workup and treatment.
see Arm Description

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean change from baseline in results on the Fertility Quality of Life tool
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the Fertility Quality of Life (FertiQoL) Core Scale, subscales and Treatment Module
through study completion, an average of 2 years
Mean change from baseline in results on the SCREENIVF tool
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the SCREENIVF tool and its subscales
through study completion, an average of 2 years
Clinical pregnancy
Time Frame: through study completion, an average of 2 years
Rate of clinical pregnancies at post-measurement
through study completion, an average of 2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean change from baseline on a Likert scale measuring strength of intention to continue treatment
Time Frame: through study completion, an average of 2 years
Mean change from baseline on a 10-point Likert scale measuring strength of intention to continue treatment (if first ART cycle not successful) to post-measurement
through study completion, an average of 2 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean change from baseline in results on the Beck Depression Inventory
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 21-item Beck Depression Inventory (BDI), with special attention to category change (e.g. from moderate to mild depression level, from mild to no depression)
through study completion, an average of 2 years
Mean change from baseline in results on the World Health Organisation-Five Well-Being Index
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 5-item World Health Organisation-Five Well-Being Index (WHO-5)
through study completion, an average of 2 years
Mean change from baseline in results on the Spielberger State-Trait Anxiety Inventory
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the State and Trait subscales of the Spielberger State Trait Anxiety Inventory (STAI)
through study completion, an average of 2 years
Mean change from baseline in results on the Short Stress Scale
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 26-item Short Stress Scale (SSS)
through study completion, an average of 2 years
Mean change from baseline in results on the Perceived Stress Scale
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 10-item Perceived Stress Scale (PSS-10)
through study completion, an average of 2 years
Mean change from baseline in results on the Life Meaning subscale of the Brief Stress and Coping Inventory
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 7-item Life Meaning subscale of the Brief Stress and Coping Inventory (BSCI-LM)
through study completion, an average of 2 years
Mean change from baseline in results on the Awareness of Mind-Body Integration and the Trusting Body Sensations subscales of the Multidimensional Assessment of Interoceptive Awareness
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 12-item Awareness of Mind-Body Integration and the 3-item Trusting Body Sensations subscales of the Multidimensional Assessment of Interoceptive Awareness (MAIA)
through study completion, an average of 2 years
Mean change from baseline in results on the Fertility Problem Stress Scales and the Coping Strategy Scales of the Copenhagen Multi-centre Psychosocial Infertility study questionnaire
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 14-item Fertility Problem Stress Scales and the 19-item Coping Strategy Scales of the Copenhagen Multi-centre Psychosocial Infertility (COMPI) study questionnaire
through study completion, an average of 2 years
Mean change from baseline in results on the Sexual Concerns subscale of the Fertility Problem Inventory
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 8-item Sexual Concerns subscale of the Fertility Problem Inventory
through study completion, an average of 2 years
Mean change from baseline in results on the Relationship Assessment Scale
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 7-item Relationship Assessment Scale (RAS)
through study completion, an average of 2 years
Mean change from baseline in results on the Pittsburgh Sleep Quality Index
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the Pittsburgh Sleep Quality Index (PSQI)
through study completion, an average of 2 years
Mean change from baseline in results on the Athens Insomnia Scale
Time Frame: through study completion, an average of 2 years
Mean change from baseline in results on the 8-item Athens Insomnia Scale (AIS)
through study completion, an average of 2 years
Mean results on a smartphone-based Likert-scale rating momentary stress
Time Frame: through study completion, an average of 2 years
Mean results on the StressFlash smartphone-based Likert-scale rating momentary stress
through study completion, an average of 2 years
Number of oocytes retrieved
Time Frame: through study completion, an average of 2 years
Number of oocytes retrieved at transvaginal oocyte retrieval (TVOR)
through study completion, an average of 2 years
Number of oocytes fertilized
Time Frame: through study completion, an average of 2 years
Number of oocytes fertilized via IVF/ICSI
through study completion, an average of 2 years
Number of embryos transferred
Time Frame: through study completion, an average of 2 years
Number of embryos transferred at embryo transfer (ET)
through study completion, an average of 2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: György Purebl, PhD Ass.Prof, Institute of Behavioural Sciences, Semmelweis University, Budapest

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 15, 2019

Primary Completion (Anticipated)

July 1, 2023

Study Completion (Anticipated)

August 1, 2023

Study Registration Dates

First Submitted

October 28, 2019

First Submitted That Met QC Criteria

November 2, 2019

First Posted (Actual)

November 5, 2019

Study Record Updates

Last Update Posted (Actual)

May 3, 2023

Last Update Submitted That Met QC Criteria

May 2, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility, Female

Clinical Trials on Mind/Body Program for Fertility (Domar et al., 2011)

Subscribe